Detection of Liver Lesions with Gadolinium-enhanced VIBE Sequence in Comparison with SPIO-enhanced MRI;Detektion von Leberläsionen mit der Gadolinium-verstärkten VIBE-Sequenz im Vergleich zur SPIO-verstärkten MRT

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 175, Issue 10, 2003, Pages 1376-1383

  Heim, P ^a   Steiner, P ^a   Schoder, V ^a   Dieckmann, C ^a   Kuhlencordt, R ^a   Adam, G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Contrast agent; MR1; SPIO; Superparamagnetic iron oxide (SPIO); Volumetric interpolated breath hold examination (VIBE)

Indexed keywords

GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STANDARD; VOLUMETRIC INTERPOLATED BREATH HOLD EXAMINATION;

ADULT; AGED; ARTIFACTS; BIOPSY; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IRON; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; OXIDES; SENSITIVITY AND SPECIFICITY;

EID: 0242363324     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42891     Document Type: Article

References (26)

1. Lüning M, Kock M, Abet L, Wolff H, Wenig B, Buchali K, Schöpke W, Schneider T, Mühler A, Rudolph B. Treffsicherheit bildgebender Verfahren (Sonographie, MRT, Angio-CT, Nuklearmedizin) bei der Charakterisierung von Lebertumoren. Fortschr Röntgenstr 1991; 154 (4): 398-406
2. Sica GT, Ji H, Ros PR. CT and MR Imaging of Hepatic Metastases. AJR 2000; 174: 691-698
3. Hagspiel KD, Neidl KFW, Eichenberger AC, Weder W, Marincek B. Detection of Liver Metastases: Comparison of Superparamagnetic Iron Oxide-enhanced and Unenhanced MR Imaging at 1.5 T with Dynamic CT, Intrapoerative US, and Percutaneous US. Radiology 1995; 196: 471-478
4. Matsuo M, Kanematsu M, Murakami T, Kim T, Hori M, Kondo Hnakamura H, Hoshi H. T2-Weighted MR Imaging for Focal Hepatic Lesion Detection: Supplementary Value of Breath-hold Imaging With Half-Fourier Single-Shot Fast Spin-Echo and Multishot Spin-Echo Echoplanar Sequences. J Mag Res Imag 2000; 12: 444-452
5. Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J. Liver Metastases: Safety and Efficacy of Detection with Superparamagnetic Iron Oxide in MR Imaging. Radiology 1994; 193: 657-663
6. Blakeborough A, Ward J, Wilson D, Griffiths M, Kajiya Y, Guthrie JA, Robinson PJ. Hepatic Lesion Detection at MR Imaging: A Comparative Study with Four Sequences. Radiology 1997; 203: 759-765
7. Daldrup HE, Reimer P, Rummeny EJ, Tombach B, Berns T, Balzer T, Schimpfky C, Peters PE. Neue superparamagnetische Eisenpartikel für die MRT. Radiologe 1995; 35: 486-493
8. Fretz CJ, Stark DD, Metz CE, Elizondo G, Weissleder R, Shen JH, Wittenberg J, Simeone J, Ferrucci JT. Detection of Hepatic Metastases: Comparison of Contrast-Enhanced CT, Unenhanced MR Imaging, and Iron-Oxide-Enhanced MR Imaging. AJR 1990; 155: 763-770
9. Halavaara JT, Lamminen AE, Bondestam S, Standertskjöld-Nordenstam CG, Hamberg LM. Detection of Focal Liver Lesions with Superparamagnetic Iron Oxide: Value of STIR and SE Imaging. J Comput Assist Tomogr 1994; 18 (6): 897-904
10. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI. Conspicuity of Hepatocellular Nodular Lesions in Cirrhotic Livers at Ferumoxides-enhanced MR Imaging: Importance of Kupffer Cell Number. Radiology 2001; 220: 669-676
11. Marchal G, van Hecke P, Demaerel P, Decrop E, Kennis C, Baert AL, van der Schueren E. Detection of Liver Metastases with Superparamagnetic Iron Oxide in 15 Patients: Results of MR Imaging at 1.5 T. AJR 1989; 152: 771-775
12. Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA, Jacobs PM. Hepatic MR Imaging with Ferumoxides: A Multicenter Clinical Trail of the Safety and Efficacy in the Detection of Focal Hepatic Lesions. Radiology 1995; 196: 481-488
13. Van Beers BE, Lacrosse M, Jamart J, Grandin C, Gigot J-F, Horsmans Y, Demeure R, Pringot J. Detection and Segmental Location of Malignant Hepatic Tumors: Comparison of Ferumoxides-Enhanced Gradient-Echo and T2-Weighted Spin-Echo MR Imaging. AJR 1997; 168: 713-717
14. Vogl TJ, Hammerstingl R, Schwarz W, Mack MG, Müller PK, Pegios W, Keck H, Eibl-Eibesfeldt A, Höelzl J, Woessmer B, Bergman C, Felix R. Superparamagnetic Iron Oxide-enhanced versus Gadolinium-enhanced MR Imaging for Differential Diagnosis of Focal Liver Lesions. Radiology 1996; 198: 881-887
15. Ward J, Chen F, Guthrie JA, Wilson D, Lodge JPA, Wyatt JI, Robinson PJ. Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-Weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis. Radiology 2000; 214: 159-166
16. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative-Free Response Receiver Operating Characteristic. Radiology 1999; 210: 459-466
17. Winter III TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas Jr. CR, Elliott S. MR Imaging with IV Superparamagnetic Iron Oxide: Efficacy in the Detection of Focal Hepatic Lesions. AJR 1993; 161: 1191-1198
18. Yamamoto H, Yasuyuki Y, Yoshimatsu S, Baba Y, Hatanaka Y, Murakami R, Nishiharu T, Takahashi M, Higashida Y, Moribe N. Hepatocellular Carcinoma in Cirrhotic Livers: Detection with Unenhanced and Iron Oxide-Enhanced MRI. Radiology 1996; 211: 277-278
19. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC. Abdominal MR Imaging with a Volumetric Interpolated Breath-hold Examination. Radiology 1999; 212: 876-884
20. Urhahn R, Adam G, Keulers P, Kilbinger M, Günther RW. Erkennbarkeit fokaler Leberläsionen: Vergleich von MRT bei 1,5 T und dynamischer Spiral-CT. Fortschr Röntgenstr 1996; 164,4: 301-307
21. Agresti A. Categorial Data Analysis. Wiley NY, 1990
22. Büning H, Trenkler G. Nichtparametrische statistische Methoden. deGruyter, 1994; 2
23. Chakraborty DP, Winter LHL. Free-Response Methodology: Alternate Analysis and a New Observer-Performance Experiment. Radiology 1990; 174: 873-881
24. Grimm J, Müller-Hülsbeck S, Blume J, Biederer J, Heller M. Vergleich von Doppel-Spiral-CT und MnDPDP-verstärkter MRT zur Erfassung und Charakterisierung von Leberläsionen. Fortschr Röntgenstr 2001; 173: 266-272
25. Vogl TJ, Schwarz W, Hammerstingl R, Kümmel S, Balzer JO, Mack MG, Diebold T, Balzer T, Shamsi K, Bechstein WO, Schrem H, Neuhaus P, Felix R. Dynamische und statische MRT mit dem superparamagnetischen MRT-Kontrastmittel Resovist® zur Darstellung von primären und sekundären Lebertumoren. Fortschr Röntgenstr 1997; 167 (3): 264-273
26. Dobritz M, Radkow T, Nittka M, Bautz W, Fellner FA. VIBE mit paralleler Akquisitionstechnik - eine neue Möglichkeit der dynamischen kontrastverstärkten MRT der Leber. Fortschr Röntgenstr 2002; 174: 738-741